Mirum Pharmaceuticals Reports Third Quarter 2024 Financial ...

Third quarter 2024 global net product sales of $90.3 million grew 89% compared to the third quarter 2023. · Third quarter 2024 LIVMARLI net sales ...

In This Article: · Third quarter 2024 global net product sales of $90.3 million grew 89% compared to the third quarter 2023. · Third quarter 2024 ...

Event Details - Mirum Pharmaceuticals, Inc. - Investor Relations

Event Details · Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update · Email Alerts.

Mirum Pharmaceuticals Third Quarter 2024 Earnings - Yahoo Finance

Mirum Pharmaceuticals ( NASDAQ:MIRM ) Third Quarter 2024 Results Key Financial Results Revenue: US$90.4m (up 89% from...

Mirum Pharmaceuticals, Inc. - Investor Relations

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update ... Media Contact. Erin Murphy. 510-508-6521 · media@mirumpharma.

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial ...

Mirum Pharmaceuticals (Nasdaq: MIRM) reported third-quarter 2024 financial results, showcasing a significant growth in net product sales, ...

News Releases - Mirum Pharmaceuticals, Inc. - Investor Relations

Nov 12, 2024. Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update · Read More. Nov 8, 2024. Mirum Pharmaceuticals ...

Earnings call: Mirum Pharmaceuticals reports robust Q3 2024 results

Mirum Pharmaceuticals, Inc. (MIRM) announced a significant increase in net product sales during the third quarter of 2024, marking an 89% ...

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised

Mirum Pharmaceuticals, Inc. MIRM incurred a loss of 30 cents per share in third-quarter 2024, much narrower than the Zacks Consensus ...

Mirum Pharmaceuticals, Inc. (MIRM) Q3 2024 Earnings Call ...

Mirum Pharmaceuticals reported a significant growth in Q3 2024 with net product sales reaching $90.3 million, an 89% increase from Q3 2023. The ...

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial ...

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update · Download · Smart Multimedia Gallery.

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial ...

Other Company's News · Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 · Mirum ...

Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial R

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report third quarter 2024 financial results on November 12, 2024. Mirum ...

Mirum Pharmaceuticals, Inc. - Events & Presentations

Archived Events ; Nov 12, 2024 8:30 AM ET. Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update ; Sep 18, 2024 1:55 PM ...

Home - Mirum Pharma

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update · Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq ...

Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial ...

Mirum Pharmaceuticals (NASDAQ: MIRM) has scheduled its third quarter 2024 financial results announcement and conference call for November 12 ...

Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial ...

FOSTER CITY, Calif. --(BUSINESS WIRE)--Nov. 4, 2024-- Mirum Pharmaceuticals , Inc. (NASDAQ: MIRM) today announced that it will ...

Mirum Pharmaceuticals, Inc. Reports Earnings Results for the Third ...

Mirum Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company ...

Mirum Pharmaceuticals - X.com

Today, we reported third quarter 2024 financial results. Tune in at 8:30 a.m. ET/5:30 a.m. PT to hear a business update from our executive ...

Mirum Pharmaceuticals Reports Strong Q3 Sales Growth - TipRanks

In its third-quarter earnings report for 2024, Mirum Pharmaceuticals announced a significant increase in global net product sales, reaching ...